Theme 4. The “How to” stream
At the conclusion of this presentation, participants will be able to explain the advantages of FIT for colorectal cancer screening. Learning Objective: At the conclusion of this presentation, participants will be able to identify how colorectal cancer screening in Ontario is changing. Learning Objective: At the conclusion of this presentation, participants will be able to recognize how to make changes to their colorectal cancer screening practices.
Cancer Care Ontario is changing its recommended screening test for patients at average risk of colorectal cancer (CRC) from the guaiac fecal occult blood test (gFOBT) to the fecal immunochemical test (FIT). FIT is a more sensitive screening test for CRC compared to gFOBT, and detects twice as many advanced neosplasias (including CRC and advanced adenomas). Given FIT’s greater ease of use, it is also expected to increase participation in screening. While FIT, like gFOBT, is an at-home fecal based test, it has different stability and storage requirements, which, together with its increased performance, will require important changes in Cancer Care Ontario’s colorectal cancer screening program design. These changes will have important implications for primary care providers, including how FIT kits will be ordered for patients, how they will be distributed to eligible Ontarians, and how patients will return completed kits. This interactive presentation will provide primary care providers with an overview of the anticipated changes with FIT, and how they can prepare their practice to ensure a smooth transition to FIT.
In addition to learning how to screen eligible patients for CRC with FIT, and how to order FIT, providers will also learn about how to refer patients with abnormal results for follow-up, and where to go for resources. The presentation will be given by Dr. Edward Kucharski and include FIT-specific case studies, which will reinforce the information provided in the presentation and increase participant interactivity.